DBV Technologies
DBVT
9.76
-0.01
-0.10%
DBV Technologies
US · DBVT
#3611 by market cap
Listed 2015
9.76
-0.01
-0.10%
Live - 5344 symbols - heartbeat 412s ago
· 2026-10-08 09:59
Pre-market
9.76
-0.10%
After-hours
9.32
-4.61%
Overnight
9.62
-1.54%
- Market cap
- 613.40M
- P/E (TTM)i
- -2.79
- P/Bi
- 3.82
- EPSi
- -5.25
- Div yieldi
- 0.00%
- 52W posi
- 1%
Reader sentiment
Are you bullish or bearish on DBVT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership rose 21.6 percentage points.
Institutional ownership
- Held by institutions
- 105.93% +21.64pp
- Institutions
- 101 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
VC/PE Fund41.62%
Hedge Fund27.91%
Public Company17.44%
Mutual Fund17.14%
Family Office/Trust0.81%
Private Company0.80%
Government Pension Fund0.20%
Top holders as of 2026-09-28
JPMorgan Chase & Co.
13.39% · 7.93M sh
RA Capital Management, L.P.
12.36% · 7.32M sh
MPM BioImpact LLC
11.34% · 6.71M sh
Baker Bros. Advisors LP
7.93% · 4.69M sh
Montanova Capital, LLC
7.92% · 4.69M sh
Artal Group S.A.
6.53% · 3.86M sh
Artisan Partners Limited Partnership
6.28% · 3.72M sh
Janus Henderson Group plc
5.22% · 3.09M sh
Adage Capital Management, L.P.
4.59% · 2.72M sh
Bpifrance Participations SA
3.68% · 2.18M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
40 filings tracked · 22 buys · 13 sells
| Name | Role | Stake |
|---|---|---|
| Pharis Mohideen | Chief Medical Officer | 0.02% |
| Michel de Rosen | Independent Chairperson | 0.01% |
| Virginie Simone Jeanine Boucinha | Chief Financial Officer | 0.00% |
| Timothy Morris | Independent Director | 0.00% |
| Adora Ndu | Independent Director | 0.00% |
| Julian Baker | -- | -- |
| Daniel Tassé | Chief Executive Officer | -- |
| Bpifrance Participations SA | -- | -- |
| Kevin Trapp | Former Chief Commercial Officer | -- |
| EPIC Bpifrance, Asset Management Arm | -- | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-07-28 | Pharis Mohideen | Chief Medical Officer | Private Disposition | -464 | $2.70 |
| 2026-01-28 | Pharis Mohideen | Chief Medical Officer | Private Disposition | -534 | $4.86 |
| 2026-01-11 | Julian Baker | -- | Other Derivative Acquisition | +27,304,896 | -- |
| 2025-12-17 | Bpifrance Participations SA | -- | Private Disposition | -3,369,093 | $4.19–5.28 |
| 2025-11-20 | Daniel Tassé | Chief Executive Officer | Other Derivative Acquisition | +964,000 | $2.90 |
| 2025-11-20 | Virginie Simone Jeanine Boucinha | Chief Financial Officer | Other Acquisition | +32,000 | -- |
| 2025-11-20 | Virginie Simone Jeanine Boucinha | Chief Financial Officer | Other Derivative Acquisition | +192,000 | $2.90 |
| 2025-11-20 | Pharis Mohideen | Chief Medical Officer | Private Disposition | -8,120 | $2.77–2.88 |
| 2025-11-20 | Pharis Mohideen | Chief Medical Officer | Other Acquisition | +44,000 | -- |
| 2025-11-20 | Pharis Mohideen | Chief Medical Officer | Other Derivative Acquisition | +253,000 | $2.90 |
| 2025-11-20 | Kevin Trapp | Former Chief Commercial Officer | Other Acquisition | +55,000 | -- |
| 2025-11-20 | Kevin Trapp | Former Chief Commercial Officer | Other Derivative Acquisition | +316,250 | $2.90 |
| 2025-07-28 | Pharis Mohideen | Chief Medical Officer | Private Disposition | -464 | $2.22 |
| 2025-05-21 | Pharis Mohideen | Chief Medical Officer | Private Disposition | -397 | $1.84 |
| 2025-03-26 | Julian Baker | -- | Other Derivative Acquisition | +27,304,896 | -- |
| 2025-03-26 | Bpifrance Participations SA | -- | Initial Statement of Beneficial | 0 | -- |
| 2025-03-26 | EPIC Bpifrance, Asset Management Arm | -- | Initial Statement of Beneficial | 0 | -- |
| 2025-01-29 | Pharis Mohideen | Chief Medical Officer | Private Disposition | -600 | $0.85 |
| 2024-12-03 | Daniel Tassé | Chief Executive Officer | Other Derivative Acquisition | +813,200 | $0.89 |
| 2024-11-24 | Pharis Mohideen | Chief Medical Officer | Private Disposition | -565 | $0.57 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 09:59:15 · For reference only, not investment advice and not tailored to your situation.